| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $8.1M | +23.3% | +64.4% |
| SG&A Expense | $3.3M | -1.8% | -9.6% |
| Operating Income | -$13.4M | -28.8% | -129.1% |
| Income Tax | -$46K | -168.7% | -453.8% |
| Net Income | -$13.4M | +16.2% | -144.8% |
| EPS (Basic) | -$0.25 | +26.5% | -92.3% |
| EPS (Diluted) | -$0.25 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.5M | -61.7% | — |
| Current Assets | $29.2M | -21.8% | -43.5% |
| Total Assets | $109.9M | -6.2% | -13.1% |
| Current Liabilities | $26.0M | +248.8% | +380.1% |
| Long-term Debt | $0 | -100.0% | -100.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.9M | — | — |
| Capital Expenditures | $348K | — | — |
| Investing Cash Flow | $15.2M | — | — |
| Financing Cash Flow | $15.9M | — | — |
| Free Cash Flow | -$31.3M | — | — |
| +26.5% |
| -92.3% |
| $108.8M |
| +3.2% |
| +33.4% |
| Stockholders' Equity | $1.1M | -91.0% | -97.6% |